JY
TARA icon

Jeff Yass’s Protara Therapeutics TARA Stock Holding History

Jeff Yass’s Portfolio TARA Stock Details TARA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-27,100
Closed -$141K – 14500
2026
Q1 		$141K Sell
27,100
-500
-2% -$2.96K ﹤0.01% 12076
2025
Q4 		$147K Buy
+27,600
New +$153K ﹤0.01% 11191
2025
Q3 		– Sell
-16,000
Closed -$48.5K – 13842
2025
Q2 		$48.5K Sell
16,000
-294,000
-95% -$1.01M ﹤0.01% 12121
2025
Q1 		$1.32M Buy
310,000
+260,700
+529% +$1.16M ﹤0.01% 6547
2024
Q4 		$260K Buy
+49,300
New +$159K ﹤0.01% 10135
2024
Q3 		– Sell
-16,600
Closed -$34.5K – 13020
2024
Q2 		$34.5K Buy
+16,600
New +$48.5K ﹤0.01% 11532
2021
Q4 		– Sell
-17,100
Closed -$118K – 13893
2021
Q3 		$118K Buy
+17,100
New +$133K ﹤0.01% 11961

Other funds holding TARA

JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $164M AUM 542.31% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Blackstone Inc
Blackstone Inc New York $32.9B AUM 23.66% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
SCM
Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
IHAM
Integral Health Asset Management New York $2.53B AUM 154.61% 1-Year Est. Return

Jeff Yass's TARA Position: Q2 2026 in Review

Jeff Yass reduced its Protara Therapeutics (TARA) stake by 65% in Q2 2026, selling an estimated $363K and leaving 40,380 shares worth $154K. The position accounts for ﹤0.01% of the portfolio, ranked #12185.

Jeff Yass first reported a position in TARA in Q1 2017 and has held it in 22 quarters since. The position peaked at $1.17M in Q1 2025. 118 funds tracked by Wall St. Rank hold TARA as of Q2 2026.

  • Jeff Yass held 40,380 shares of Protara Therapeutics worth $154K as of Q2 2026.
  • Jeff Yass sold 76,246 Protara Therapeutics shares in Q2 2026, an estimated $363K.
  • Protara Therapeutics made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #12185 holding.
  • Jeff Yass first reported a position in Protara Therapeutics in Q1 2017 and has held it in 22 quarters since.
  • Jeff Yass's Protara Therapeutics position peaked at $1.17M in Q1 2025.
  • 118 funds tracked by Wall St. Rank held Protara Therapeutics as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.